Protagenic Therapeutics exec. chair Garo Armen buys $13,000 in shares
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
Geoff Whyte, Group CEO of AdvTech, shares the synergy between educational divisions and continental value proposition of the organisation.
(RTTNews) - The Switzerland market ended marginally down on Monday after a choppy ride as investors refrained from making significant moves amid a lack of fresh catalysts.
As we lumber into an expanded trade war with Canada: Source: Census via ITA, and author’s calculations. To date (1pm CT), gubernatorial candidate Tom Tiffany has not made a comment on the original…